Stem-cell‑derived exosomes: a comprehensive review from basic biology to clinical translation challenges
New Medicine · 2026-06 · 4 (2) · 112-120
DOI: 10.1097/nm9.0000000000000004 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Medicine, online erschienen am 07.07.2026. Verfasst von Md Toufic Hasan und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Stem-cell-derived exosomes (SC-Exos) have emerged as promising cell-free therapeutic platforms in regenerative medicine because they retain many of the paracrine, immunomodulatory, and tissue-repair functions of their parent cells while potentially reducing the risks associated with direct stem-cell transplantation. Increasing evidence suggests that exosomes derived from mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs), and tissue-specific progenitor cells participate in intercellular communication through the delivery of bioactive cargoes, including microRNAs, proteins, lipids, and metabolites, thereby regulating inflammation, angiogenesis, fibrosis, neuroprotection, and tissue regeneration. In this review, we summarize the current understanding of stem-cell-derived exosome biology, including their biogenesis, molecular composition, isolation strategies, engineering approaches, and functional characterization. Particular emphasis is placed on their emerging therapeutic applications in regenerative and translational medicine as well as the major challenges limiting clinical implementation. Although substantial progress has been achieved in preclinical research, important barriers remain, including heterogeneity of extracellular vesicle preparations, lack of standardized isolation and characterization methods, insufficient potency assays, limited large-scale manufacturing capability, and unresolved quality control and regulatory issues. In addition, we discuss ongoing clinical studies and current efforts to establish standardized frameworks for exosome production, safety evaluation, and therapeutic assessment in accordance with evolving international guidelines. Finally, we highlight in this review the key scientific and translational priorities required to facilitate the development of safe, reproducible, and clinically effective exosome-based therapies.
Zitieren
APA
Hasan, M. T., Hossain, M. B., Rahman, M. M., Hasan, M. S., Hasan, M., & Mithu, M. M. (2026). Stem-cell‑derived exosomes: a comprehensive review from basic biology to clinical translation challenges. New Medicine, 4(2), 112-120. https://doi.org/10.1097/nm9.0000000000000004
Vancouver
Hasan MT, Hossain MB, Rahman MM, Hasan MS, Hasan M, Mithu MM. Stem-cell‑derived exosomes: a comprehensive review from basic biology to clinical translation challenges. New Medicine. 2026;4(2):112-120. doi:10.1097/nm9.0000000000000004
BibTeX
@article{Hasan2026,
author = {Hasan, Md Toufic and Hossain, Md Billal and Rahman, Md Mahmudur and Hasan, Md Shakibul and Hasan, Mehedi and Mithu, Md Miftahul},
title = {Stem-cell‑derived exosomes: a comprehensive review from basic biology to clinical translation challenges},
journal = {New Medicine},
year = {2026},
volume = {4},
number = {2},
pages = {112--120},
doi = {10.1097/nm9.0000000000000004}
}
EUVIMED